drugset / Trial / NCT01478854
Neural Progenitor Cell Sparing Radiation Therapy Plus Temozolomide
NaSingle-groupOpen-labelTreatment
Summary
The long term goal of this research is to establish whether NPC sparing RT techniques improve neurocognitive outcomes compared to conventional RT for brain tumors. If the proposed study demonstrates that NPC sparing RT is not associated with increased LR in the spared regions of the brain compared to conventional RT, it will ideally serve as the foundation for a future multi-institutional randomized controlled trial comparing neurocognitive outcomes in patients treated with NPC-sparing RT versus conventional radiation therapy.
Timeline
- Start
- 2011-12-27
- Primary completion
- 2018-04-25
- Completion
- 2018-04-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Temozolomide | Small molecule | — | — |